Pemzayre® tablet 13.5mg

Ingredient

1 Tab(240.0mg) contains, pemigatinib (In-house spec.) 13.5mg

Content

White to off-white round tablet, one side debossed with “I”, the other side with “13.5”.

Indication

The treatment of adults with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (FGFR2) fusion or rearrangement that have progressed after one or more prior line of systemic therapy.